Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Andrographolides
DRUG
2 trials
Sponsors
Gu Yanhong
, Innobioscience SpA
Conditions
Colorectal Neoplasms
Multiple Sclerosis, Secondary Progressive
Primary Progressive Multiple Sclerosis
Phase 1
Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS
NCT02273635
Innobioscience SpA
Multiple Sclerosis, Secondary Progressive, Primary Progressive Multiple Sclerosis
Start: 2014-09-30
End: 2017-04-30
Target: 68
Updated: 2014-10-27
Phase 2
Study of Andrographolides With or Without Capecitabine to Treat Colorectal Cancer
Terminated
NCT01993472
Gu Yanhong
Colorectal Neoplasms
Start: 2013-11-30
End: 2016-12-31
Target: 308
Updated: 2020-01-14
Related Papers
Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial.
2020-05-07
26 citations
An open-label, randomized, controlled clinical trial to explore the curative effects between the treatment of capecitabine and andrographolide and the single capecitabine in the patients with pathological and/or histologic diagnosed unresectable, advanced, recurrent, and metastatic colorectal cancer.
Journal of Clinical Oncology
2017-02-01
13 citations